23 Jul, 2026
According to Straits Research, the global intraoperative radiation therapy market size is valued at $129.01 million in 2025 and is estimated to reach $260.67 million by 2034, registering a CAGR of 8.17% during the forecast period 2026–2034.
The global intraoperative radiation therapy (IORT) market is witnessing steady growth, primarily driven by the rising prevalence of various cancers and the growing demand for precise, targeted radiation therapies that minimize exposure to surrounding healthy tissues. Increasing incidences of breast, brain, gastrointestinal, and head and neck cancers worldwide are fueling the adoption of IORT, as this technology allows surgeons to deliver high-dose radiation directly to the tumor bed during surgery, reducing the need for prolonged post-operative radiation sessions. Additionally, advancements in mobile, compact, and image-guided IORT systems are enhancing procedural accuracy, workflow efficiency, and patient convenience, further supporting market expansion.
However, the market faces notable restraints due to the stringent regulatory and approval processes associated with medical radiation devices. IORT systems must undergo extensive clinical trials, safety evaluations, and compliance checks before market entry, which substantially increase development costs, delay commercialization, and limit the rapid adoption of innovative solutions. These regulatory complexities pose challenges for manufacturers seeking to introduce next-generation IORT technologies and may hinder the pace of market growth. On the other hand, a notable opportunity exists in the increasing integration of IORT in emerging and underserved regions, where hospitals and specialty clinics are investing in advanced cancer care infrastructure. The adoption of portable, cost-efficient, and mobile IORT devices enables broader accessibility in both urban and semi-urban centers.
sales@straitsresearch.com